DENVILLE, N.J., Aug. 14, 2008 (PRIME NEWSWIRE) -- Lantis Laser Inc.'s (Pink Sheets:LLSR) (http://www.lantislaser.com) ongoing research into the application of Optical Coherence Tomography (OCT) imaging technology demonstrates that Lantis' OCT Dental Imaging System(tm) can provide a wide array of imaging technology and modalities that can provide fast and accurate information to aid in the diagnosis of dental disease and microstructural defects.
OCT researchers have shown the ability of OCT to be used for wide-area scanning as a screening aid as well as a micro scanning device for obtaining detailed quantitative and qualitative information to aid dental professionals in making diagnostic decisions. Recent research has also shown that the use of nano particles can further enhance diagnostic ability of OCT.
Stan Baron, President & CEO of Lantis commented that, "The concept of macro imaging, micro imaging and nano imaging with OCT can provide dentists with the diagnostic aid needed to practice minimally invasive dentistry and transition to the medical model -- find disease early and treat it early. The possibilities presented by OCT technology and new research findings are very exciting and Lantis will continue to pursue relationships with research institutions where these concepts are being developed for commercial implementation."
Lantis has a strong OCT portfolio of licensed intellectual property and a strategic supply agreement for its OCT Engine with Axsun Technologies that ensures its dominance in the dental market for this next generation diagnostic imaging modality. Its OCT system provides chairside, real-time images of dental structures at a resolution of up to 10 times x-ray, and as it is light-based there is no harmful radiation. Providing more detailed information than x-ray, it is anticipated that it will likely become the dominant imaging modality in the dental office, after its introduction which is targeted for first quarter 2009.
About Lantis Laser
Lantis was formed to commercialize the application of novel technologies in the dental industry. The criteria for selected products include competitive edge, exclusivity and large market potential. Lantis is currently in Phase 2 and Phase 3 development, moving through beta systems, product development and application for FDA clearance and plans to launch the OCT Dental Imaging System(tm) in the first quarter of 2009. Lantis has exclusive rights to the application of OCT technology in the field of dentistry under its license Agreements with Lawrence Livermore National Laboratory (exclusive); Lightlab Imaging (non-exclusive) and AXSUN (exclusive). To find out more about Lantis Laser (Pink Sheets:LLSR), visit www.lantislaser.com
Safe Harbor: Statements regarding financial matters in this press release other than historical facts are "forward-looking statements" within the meaning of section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934, and as that term is defined in the Private Securities Litigation Reform Act of 1995. The company intends that such statements about the Company's future expectations, including future revenues and earnings, technology efficacy and all other forward-looking statements be subject to the safe harbors created thereby. The Company is a development stage company who continues to be dependent upon outside capital to sustain its existence. Since these statements (future operational results and sales) involve risks and uncertainties and are subject to change at any time, the Company's actual results may differ materially from expected results.
For OCT Updates